Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a backend or interface release rather than a change to the trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:51.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Page version updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T01:15:22.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    - Updated page revision from v3.4.2 to v3.4.3. - No substantive changes to study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-11T18:04:13.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The Study Record Dates now display 'Results Submitted' instead of 'No Results Posted', indicating that results have been submitted.
    Difference
    0.1%
    Check dated 2026-02-18T07:52:49.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    An update adds a new footer revision tag 'Revision: v3.4.2' and removes an outdated 'Notice' about government funding as well as the prior 'Revision: v3.4.1' tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:00:49.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.